The Effect of Intravenous L-carnitine on Propionic Acid Excretion in Acute Propionic Acidaemia
Overview
Affiliations
A 6-week-old female infant presented in a severe metabolic crisis from propionic acidaemia. The condition was aggravated by pneumonia and heart insufficiency. In addition to the general supportive measures and caloric intake exclusively from glucose, intravenous L-carnitine treatment (2 g L-carnitine/24 h) was started to enhance propionic acid excretion as a carnitine conjugate. Despite the therapeutic efforts the patient died about 48 h after admission in sudden respiratory arrest and bradycardia. Serum propionic acid concentration was increased to 0.3 mumol/ml. Propionylcarnitine excretion was measured and about 55% of the overall excretion during the 48 h treatment period was attributed to an effect of carnitine administration. 2-methylcitrate and 2-methyl-3-oxovaleric acid excretion decreased during the same period. Obviously carnitine was not able to prevent metabolic deterioration but may provide some additional "buffer capacity" during long-term dietary treatment.
Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.
Lehnert W, Sperl W, Suormala T, Baumgartner E Eur J Pediatr. 1994; 153(7 Suppl 1):S68-80.
PMID: 7957390 DOI: 10.1007/BF02138781.
Brass E, Beyerinck R Biochem J. 1988; 250(3):819-25.
PMID: 3134008 PMC: 1148929. DOI: 10.1042/bj2500819.
Haemodialysis for metabolic decompensation in propionic acidaemia.
Roth B, Skopnik H, Leonard J, Lehnert W J Inherit Metab Dis. 1987; 10(2):147-51.
PMID: 3116333 DOI: 10.1007/BF01800040.